Cargando...
Drug Targeting of Dysregulated Transcription in Huntington’s Disease
Transcriptional dysregulation in Huntington’s disease (HD) is a well documented and broadly studied phenomenon. Its basis appears to be in huntingtin’s aberrant protein-protein interactions with a variety of transcription factors. The development of therapeutics targeting altered transcription, howe...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2007
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2110959/ https://ncbi.nlm.nih.gov/pubmed/17379386 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.pneurobio.2007.02.005 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|